Cancer
Conditions
Keywords
drug clinical trials, cancer patients, willingness
Brief summary
The goal of this observational study is to develop a scale for cancer patients' willingness to voluntarily participate in drug clinical trials and evaluate its reliability and validity.
Detailed description
Inclusion Criteria: 1. Age 18-80 years old (including boundary values). 2. Tumor patients with clear diagnosis. 3. Whether they finally sign the informed consent form of one drug clinical trial or not, and whether they are finally enrolled in one drug clinical trial or not, patients who have undergone the informed consent process of drug clinical trials conducted by clinicians can be enrolled in this study. 4. Volunteer to participate in this study and sign an informed consent form. Exclusion Criteria: 1. Patients with unclear consciousness. 2. Patients who are unable to correctly understand and answer questions. 3. Vulnerable subjects include: students and subordinates of researchers, military personnel, prisoners, patients with incurable diseases, patients in critical situations, those admitted to welfare institutions, homeless individuals, minors, and those who are unable to provide informed consent.
Interventions
None listed
Sponsors
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Study design
Observational model
OTHER
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
1. Age 18-80 years old (including boundary values). 2. Tumor patients with clear diagnosis. 3. Whether they finally sign the informed consent form of one drug clinical trial or not, and whether they are finally enrolled in one drug clinical trial or not, patients who have undergone the informed consent process of drug clinical trials conducted by clinicians can be enrolled in this study. 4. Volunteer to participate in this study and sign an informed consent form.
Exclusion criteria
1. Patients with unclear consciousness. 2. Patients who are unable to correctly understand and answer questions. 3. Vulnerable subjects include: students and subordinates of researchers, military personnel, prisoners, patients with incurable diseases, patients in critical situations, those admitted to welfare institutions, homeless individuals, minors, and those who are unable to provide informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| A semi-structured interview | 3 months | A semi-structured interview is conducted to investigate the willingness of cancer patients to participate in drug clinical trials and its influencing factors. The researcher will analyze the interview results and summarize several themes that reflect the willingness. |
Countries
China
Contacts
Primary ContactCaie Chen
Outcome results
None listed